These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20061300)

  • 1. Clinical classification and treatment of congenital and acquired lipodystrophy.
    Chan JL; Oral EA
    Endocr Pract; 2010; 16(2):310-23. PubMed ID: 20061300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to diagnose a lipodystrophy syndrome.
    Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
    Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
    Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for leptin-replacement therapy for severe lipodystrophy.
    Oral EA; Chan JL
    Endocr Pract; 2010; 16(2):324-33. PubMed ID: 20061299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?
    Mantzoros CS
    Endocr Pract; 2010; 16(2):162-6. PubMed ID: 20350904
    [No Abstract]   [Full Text] [Related]  

  • 6. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism.
    Hegele RA; Joy TR; Al-Attar SA; Rutt BK
    J Lipid Res; 2007 Jul; 48(7):1433-44. PubMed ID: 17374881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice.
    Wang M; Gao M; Liao J; Han Y; Wang Y; Liu G
    Biochem Biophys Res Commun; 2015 May; 461(2):206-10. PubMed ID: 25866184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized lipoatrophy syndromes.
    Sorkina E; Chichkova V
    Presse Med; 2021 Nov; 50(3):104075. PubMed ID: 34562560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited lipodystrophies and hypertriglyceridemia.
    Simha V; Garg A
    Curr Opin Lipidol; 2009 Aug; 20(4):300-8. PubMed ID: 19494770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue].
    Capeau J; Vigouroux C; Magré J; Lascols O; Caron M; Bastard JP
    C R Biol; 2006 Aug; 329(8):639-52; discussion 653-5. PubMed ID: 16860281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.
    Tchang BG; Shukla AP; Aronne LJ
    Expert Opin Biol Ther; 2015 Jul; 15(7):1061-75. PubMed ID: 26063386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of congenital lipodystrophies].
    Buffet A; Lombes M; Caron P
    Ann Endocrinol (Paris); 2015 Oct; 76(6 Suppl 1):S2-9. PubMed ID: 26776286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
    Boutet E; El Mourabit H; Prot M; Nemani M; Khallouf E; Colard O; Maurice M; Durand-Schneider AM; Chrétien Y; Grès S; Wolf C; Saulnier-Blache JS; Capeau J; Magré J
    Biochimie; 2009 Jun; 91(6):796-803. PubMed ID: 19278620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.
    Vigouroux C; Caron-Debarle M; Le Dour C; Magré J; Capeau J
    Int J Biochem Cell Biol; 2011 Jun; 43(6):862-76. PubMed ID: 21392585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G; Akinci B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Cellular Bases of Lipodystrophy Syndromes.
    Zammouri J; Vatier C; Capel E; Auclair M; Storey-London C; Bismuth E; Mosbah H; Donadille B; Janmaat S; Fève B; Jéru I; Vigouroux C
    Front Endocrinol (Lausanne); 2021; 12():803189. PubMed ID: 35046902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Options for Lipodystrophy in Children.
    Mainieri F; Tagi VM; Chiarelli F
    Front Endocrinol (Lausanne); 2022; 13():879979. PubMed ID: 35600578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophies: disorders of adipose tissue biology.
    Garg A; Agarwal AK
    Biochim Biophys Acta; 2009 Jun; 1791(6):507-13. PubMed ID: 19162222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.
    Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diseases of adipose tissue: genetic and acquired lipodystrophies.
    Capeau J; Magré J; Lascols O; Caron M; Béréziat V; Vigouroux C; Bastard JP
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1073-7. PubMed ID: 16246048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.